U.S. drug developer Raptor Pharmaceuticals explores sale -sources

April 6 (Reuters) - Raptor Pharmaceutical Corp, which develops drugs that treat orphan diseases, is in discussions with investment banks to hire a financial adviser to explore a potential sale, according to people familiar with the matter.